Product How it works Pricing Blog FAQ About Contact
TriSalus Life Sciences

TriSalus Life Sciences (NASDAQ: TLSI) net income

TriSalus Life Sciences reported a net loss of $39.2m for fiscal 2025; in fiscal 2024 it reported a net loss of $30.0m. Earnings per share were −$1.84.

TriSalus Life Sciences's best year of the last 5 was fiscal 2021. It reported a loss in 4 of those 5 years.

Net income, in millions of US dollars4.82021-47.22022-59.42023-30.02024-39.22025
Embed this chart

Copy this code into your website or blog. The chart updates with each new annual report.

Net income by fiscal year

Fiscal yearNet incomeChangeNet marginEarnings per share
2025−$39.2m—−86.9%−$1.84
2024−$30.0m—−102.1%−$1.31
2023−$59.4m—−320.7%−$6.73
2022−$47.2m−1,089.8%−380.6%−$161.55
2021$4.8m———

The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.

TriSalus Life Sciences net income compared with its sector

By net income for its latest fiscal year, TriSalus Life Sciences ranks 240th of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of TriSalus Life Sciences, −86.9%.

RankCompanyNet incomeNet margin
238thRxSight−$38.9m−29.0%
239thSpruce Biosciences−$39.0m—
240thTriSalus Life Sciences−$39.2m−86.9%
241stElicio Therapeutics−$39.6m—
242ndOrthoPediatrics−$39.6m−16.8%

Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.

Questions about the net income of TriSalus Life Sciences

How much did TriSalus Life Sciences earn in fiscal 2025?
TriSalus Life Sciences reported a net loss of $39.2m for fiscal 2025. In fiscal 2024 it reported a net loss of $30.0m.
What are the earnings per share of TriSalus Life Sciences?
They were −$1.84 in fiscal 2025, compared with −$1.31 in fiscal 2024.
What was the most profitable year for TriSalus Life Sciences?
Of its last 5 fiscal years, fiscal 2021, with $4.8m.
Where does TriSalus Life Sciences rank in its sector by net income?
It ranks 240th of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
Where do the figures for TriSalus Life Sciences come from?
From the annual report (Form 10-K) that TriSalus Life Sciences files with the SEC, the US securities regulator. Each fiscal year links to its filing.

Where each figure comes from

From the annual report (Form 10-K) that TriSalus Life Sciences files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021. More on TriSalus Life Sciences: the TriSalus Life Sciences page · annual accounts · revenue · insider transactions.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.